Surgery for recurrent ovarian cancer: Options and limits

Area of Science:

• Gynecologic Oncology
• Surgical Oncology
• Ovarian Cancer Research

Background:

• Cytoreductive surgery is a cornerstone of primary ovarian cancer treatment.
• Surgical outcomes significantly impact progression-free and overall survival in ovarian cancer.
• Management of recurrent ovarian cancer remains challenging with limited prospective data on surgical impact.

Purpose of the Study:

• To review current data on the role of cytoreductive surgery in recurrent ovarian cancer.
• To identify predictive factors for complete tumor resection in relapsed ovarian cancer.
• To highlight the need for further research and standardized operative approaches.

Main Methods:

• Review of retrospective data and available prospective studies on surgery for recurrent ovarian cancer.
• Analysis of factors influencing complete cytoreduction.
• Evaluation of patient selection criteria for surgical intervention.

Main Results:

• Retrospective data suggest complete cytoreduction improves prognosis in recurrent ovarian cancer.
• Predictive factors for complete resection include prior complete cytoreduction and minimal ascites (<500 ml).
• Patients meeting these criteria have a 76% likelihood of complete resection and survival prolongation.

Conclusions:

• Complete cytoreduction in recurrent ovarian cancer is associated with improved survival.
• Patient selection based on predictive factors is essential for optimizing surgical outcomes.
• Further randomized trials are needed to establish operative standards for recurrent ovarian cancer.